Skip to main content
Top
Published in:

Open Access 01-12-2024 | Kidney Cancer | Research

Associations of physical activity and sedentary time with health-related quality of life in patients with localized renal cell cancer: a cross-sectional analysis within the ReLife study

Authors: Alina Vrieling, Jake S. F. Maurits, Job Gerritsen, Laurien M. Buffart, Katja K. H. Aben, J. P. Michiel Sedelaar, Esmée A. Bakker, Lambertus A. L. M. Kiemeney

Published in: Supportive Care in Cancer | Issue 12/2024

Login to get access

Abstract

Purpose

This study examined the associations of device-measured moderate-to-vigorous physical activity (MVPA) and sedentary time as well as self-reported MVPA with health-related quality of life (HRQoL) in patients with localized renal cell cancer (RCC) in the recovery phase after surgery.

Methods

At 3 months post-surgery, 341 patients with stage I-III RCC participating in the ReLife study wore an ActivPAL3 device to determine MVPA and sedentary time. The SQUASH questionnaire was used for assessing self-reported MVPA, and the EORTC QLQ-C30 for assessing HRQoL (range 0–100). Multivariable linear regression models were used to examine the cross-sectional associations of MVPA and sedentary time with HRQoL.

Results

The highest (≥ 6.7 h/week) versus lowest (≤ 2.7 h/week) quartile of MVPA was associated with a better global health status (β, 10.2; 95% CI, 5.1, 15.3), summary score (β, 4.6; 95% CI, 1.1, 8.1), physical (β, 7.7; 95% CI, 3.8, 11.6), role (β, 12.4; 95% CI, 4.7, 20.2), and social functioning (β, 7.3; 95% CI, 0.2, 14.4), and lower fatigue (β, − 11.2; 95% CI, − 18.1, − 4.2). Results for self-reported MVPA were in the same direction but weaker. The lowest (≤ 8.8 h/day) versus highest (≥ 11.5 h/day) quartile of sedentary time was associated with better physical functioning (β, 4.6; 95% CI, 0.8, 8.5).

Conclusions

In patients with localized RCC, higher MVPA 3 months post-surgery was associated with better HRQoL outcomes including less fatigue whereas lower sedentary time was only associated with better physical functioning. This information can contribute to the development of physical activity guidelines and interventions to improve HRQoL.
Literature
8.
go back to reference World Cancer Research Fund/American Institute for Cancer Research. Continuous update project expert report 2018. Diet, nutrition, physical activity and kidney cancer. Available at dietandcancerreport.org. World Cancer Research Fund/American Institute for Cancer Research. Continuous update project expert report 2018. Diet, nutrition, physical activity and kidney cancer. Available at dietandcancerreport.org.
13.
go back to reference Colley RC, Butler G, Garriguet D, Prince SA, Roberts KC (2018) Comparison of self-reported and accelerometer-measured physical activity in Canadian adults. Health Rep 29(12):3–15PubMed Colley RC, Butler G, Garriguet D, Prince SA, Roberts KC (2018) Comparison of self-reported and accelerometer-measured physical activity in Canadian adults. Health Rep 29(12):3–15PubMed
19.
go back to reference Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D (2003) Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 56(12):1163–1169CrossRefPubMed Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D (2003) Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 56(12):1163–1169CrossRefPubMed
21.
go back to reference World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Tech Rep Ser 894:i-xii, 1–253 World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Tech Rep Ser 894:i-xii, 1–253
24.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed
35.
go back to reference Vallance JK, Friedenreich CM, Wang Q, Matthews CE, Yang L, McNeely ML et al (2023) Associations of device-measured physical activity and sedentary time with quality of life and fatigue in newly diagnosed breast cancer patients: baseline results from the AMBER cohort study. Cancer 129(2):296–306. https://doi.org/10.1002/cncr.34531CrossRefPubMed Vallance JK, Friedenreich CM, Wang Q, Matthews CE, Yang L, McNeely ML et al (2023) Associations of device-measured physical activity and sedentary time with quality of life and fatigue in newly diagnosed breast cancer patients: baseline results from the AMBER cohort study. Cancer 129(2):296–306. https://​doi.​org/​10.​1002/​cncr.​34531CrossRefPubMed
Metadata
Title
Associations of physical activity and sedentary time with health-related quality of life in patients with localized renal cell cancer: a cross-sectional analysis within the ReLife study
Authors
Alina Vrieling
Jake S. F. Maurits
Job Gerritsen
Laurien M. Buffart
Katja K. H. Aben
J. P. Michiel Sedelaar
Esmée A. Bakker
Lambertus A. L. M. Kiemeney
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08969-3
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now